A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.

Phase 4 Active not recruiting 216 enrolled Bausch & Lomb Incorporated

RandomizedParallel-groupSingle-blindTreatment

Summary

A Randomized, Multicenter, Double-Masked, Saline-Controlled Trial to Evaluate Corneal Endothelial Cell Density in Subjects With Dry Eye Disease Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months

Timeline

Start: 2024-07-31
Primary completion: 2025-11
Completion: 2025-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Perfluorohexyloctane	Unknown	100 %	—

A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.

Summary

Timeline

Drugs

Indications